NCM
UNCY icon

Nantahala Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Nantahala Capital Management’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Buy
1,401,447
+462,245
+49% +$3.41M 0.22% 96
2026
Q1 		$6.18M Hold
939,202
– – 0.23% 91
2025
Q4 		$5.42M Hold
939,202
– – 0.18% 97
2025
Q3 		$4.09M Hold
939,202
– – 0.14% 112
2025
Q2 		$4.56M Buy
939,202
+3
+0% +$19 0.18% 95
2025
Q1 		$5.4M Sell
939,199
-100,000
-10% -$610K 0.21% 65
2024
Q4 		$8.25M Buy
1,039,199
+757,163
+268% +$4.19M 0.35% 53
2024
Q3 		$1.15M Hold
282,036
– – 0.06% 110
2024
Q2 		$1.41M Sell
282,036
-51,523
-15% -$507K 0.08% 98
2024
Q1 		$8.64M Sell
333,559
-10,259
-3% -$124K 0.49% 41
2023
Q4 		$2.98M Sell
343,818
-3,236
-0.9% -$21.2K 0.18% 82
2023
Q3 		$2.98M Buy
347,054
+282,312
+436% +$2.64M 0.26% 76
2023
Q2 		$829K Hold
64,742
– – 0.08% 96
2023
Q1 		$1.36M Hold
64,742
– – 0.1% 89
2022
Q4 		$350K Sell
64,742
-6,312
-9% -$42.7K 0.02% 104
2022
Q3 		$419K Sell
71,054
-1,914
-3% -$14K 0.03% 100
2022
Q2 		$606K Buy
72,968
+8,905
+14% +$85.1K 0.03% 104
2022
Q1 		$826K Sell
64,063
-4,613
-7% -$67.5K 0.04% 102
2021
Q4 		$1.42M Sell
68,676
-1,324
-2% -$33.1K 0.05% 113
2021
Q3 		$1.98M Buy
+70,000
New +$2.01M 0.06% 107

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Nantahala Capital Management's UNCY Position: Q2 2026 in Review

Nantahala Capital Management increased its Unicycive Therapeutics (UNCY) stake by 49% in Q2 2026, buying an estimated $3.41M and bringing the position to 1,401,447 shares worth $6.57M. The position accounts for 0.22% of the portfolio, ranked #96.

Nantahala Capital Management first reported a position in UNCY in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.64M in Q1 2024. 80 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Nantahala Capital Management held 1,401,447 shares of Unicycive Therapeutics worth $6.57M as of Q2 2026.
  • Nantahala Capital Management bought 462,245 Unicycive Therapeutics shares in Q2 2026, an estimated $3.41M.
  • Unicycive Therapeutics made up 0.22% of Nantahala Capital Management's portfolio in Q2 2026, its #96 holding.
  • Nantahala Capital Management first reported a position in Unicycive Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Nantahala Capital Management's Unicycive Therapeutics position peaked at $8.64M in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.